Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

The Risk of a European Recession Is Rising

Published

on

Chelsey Dulaney hedcut
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Nurix Therapeutics, Inc. (NRIX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Nurix Therapeutics, Inc. (NRIX) RBC Capital Markets Global Healthcare Conference 2026 May 20, 2026 1:30 PM EDT

Company Participants

Arthur Sands – CEO, President & Director
Jason Kantor – Chief Business Officer

Advertisement

Conference Call Participants

Brian Abrahams – RBC Capital Markets, Research Division

Presentation

Advertisement

Brian Abrahams
RBC Capital Markets, Research Division

So let’s get started. Good afternoon, everyone. Welcome back from lunch. I’m Brian Abrahams, senior biotech analyst here at RBC Capital Markets. We’re really pleased to have our next featured company, Nurix Therapeutics, represented by their CEO, Arthur Sands and their CBO, Jason Kantor.

Arthur Sands
CEO, President & Director

Advertisement

Great. Good to be here. Thanks, Brian.

Question-and-Answer Session

Advertisement

Brian Abrahams
RBC Capital Markets, Research Division

Thanks for being here. So maybe let’s start a little bit bigger picture on your lead program, Bexdeg. Tell us what your latest view is on the potential advantages that BTK degraders can have in the CLL space relative to the currently available inhibitors, what’s out there today? And what’s been your view as to the strongest preclinical and clinical evidence and data to date that’s really helped support that? And I know the data is continuing to evolve. So I would love to hear your latest views on that.

Arthur Sands
CEO, President & Director

Advertisement

Yes, excellent question. The advantage of targeted protein degrader in this space in CLL and in BTK, we’re seeing advantages expand and grow. So I can tell you where we started and now where we think it is, which is quite exciting.

So we started with the concept that by removing the protein, we could address certain BTK inhibitor resistance mutations, which were just emerging, if you go back to the beginning of, let’s say, 2020, 2019. So the concept that by degrading the protein through the ubiquitous proteasome system, we could address this emerging problem

Advertisement
Continue Reading

Business

James Rules Out Rebuild, Demands Championship Contention in Year 24

Published

on

Dylan Harper

LOS ANGELES — LeBron James has made it clear that he will only consider teams positioned for immediate championship contention as he prepares for his 24th NBA season, ruling out any involvement in rebuilding projects.

The 41-year-old superstar, who turns 42 in December, has not yet made a final decision on his future but is expected to inform the Los Angeles Lakers of his plans before the NBA Draft in late June. James exercised his $52.6 million player option for the 2025-26 season and will enter unrestricted free agency this summer.

Multiple sources confirm James is prioritizing winning above all else. He has shown no interest in joining franchises focused on long-term rebuilding, emphasizing his desire to compete for a fifth NBA title.

James has won four championships with three different teams — two with the Miami Heat (2012, 2013), one with the Cleveland Cavaliers (2016), and one with the Lakers (2020). He remains highly productive, averaging 20.9 points, 6.1 rebounds, and 7.2 assists per game in the 2025-26 season.

Advertisement

The Lakers are considered strong contenders to retain him, especially with Luka Doncic already on the roster. However, James has not committed to any specific outcome. His agent, Rich Paul of Klutch Sports, has remained silent on the matter.

James has a history of deliberate free agency decisions. He is unlikely to accept the veteran minimum but may take less than the maximum to help a contender build a stronger roster around him.

The Lakers hold Bird Rights and have significant cap flexibility. Their ability to surround James and Doncic with complementary talent will be a major factor in his decision.

James has spent the past six seasons with the Lakers after previous stints with the Cavaliers and Heat. His longevity continues to impress, as he ranks among the league’s top performers despite his age.

Advertisement

No official announcement has been made. James has focused on family and business interests while evaluating his options for the upcoming season.

The upcoming NBA Draft and free agency period will be pivotal. Several contending teams are monitoring the situation, though James has shown loyalty to the Lakers while keeping his options open.

James has not publicly commented on specific teams or contract details since the end of the 2025-26 season. His emphasis on championship contention remains the central theme of his decision-making process.

Advertisement
Continue Reading

Business

The Timken Company (TKR) Analyst/Investor Day Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

The Timken Company (TKR) Analyst/Investor Day May 20, 2026 9:00 AM EDT

Company Participants

Neil Frohnapple – Vice President of Investor Relations
Lucian Boldea – CEO, President & Director
John Szarka – Senior VP & Chief Technology Officer
Timothy Graham – Executive VP & President of Industrial Motion
Michael Discenza – Executive VP & CFO

Advertisement

Conference Call Participants

Bryan Blair – Oppenheimer & Co. Inc., Research Division
David Raso – Evercore ISI Institutional Equities, Research Division
Angel Castillo Malpica – Morgan Stanley, Research Division
Robert Wertheimer – Melius Research LLC
Tomohiko Sano – JPMorgan Chase & Co, Research Division
Timothy Thein – Raymond James & Associates, Inc., Research Division
Joseph Ritchie – Goldman Sachs Group, Inc., Research Division
Justin Bergner – Gabelli Funds, LLC
Steve Barger – KeyBanc Capital Markets Inc., Research Division

Presentation

Advertisement

Neil Frohnapple
Vice President of Investor Relations

Good morning, everyone. Welcome to the Timken Company’s 2026 Investor Day. My name is Neil Frohnapple, Vice President of Investor Relations for Timken. We’re excited to have many with us here in the room today in New York City, and we welcome those who are joining us virtually via webcast. We appreciate everyone taking the time to learn more about how Timken intends to elevate its performance.

Let’s start by taking a look at the agenda. This morning, you’ll hear from our President and CEO, Lucian Boldea, who will give you an overview of Timken’s strategic plan to accelerate profitable growth and structurally increase margins. Then our Chief Technology Officer, John Szarka will spend time discussing how Timken’s innovation and technology will support our growth in the next generation of motion systems. After John speaks, we’ll take a short break, and then our President of Industrial Motion, Tim Graham will take you through how we’re winning with customers and creating value as One Timken. Our final presentation today will be from Mike Discenza, Executive Vice President and CFO, as he shares more details

Advertisement
Continue Reading

Business

Nippon Sanso Holdings Corporation 2026 Q4 – Results – Earnings Call Presentation (OTCMKTS:NPXYY) 2026-05-22

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

This article was written by

Seeking Alpha’s transcripts team is responsible for the development of all of our transcript-related projects. We currently publish thousands of quarterly earnings calls per quarter on our site and are continuing to grow and expand our coverage. The purpose of this profile is to allow us to share with our readers new transcript-related developments. Thanks, SA Transcripts Team

Continue Reading

Business

Advance Auto Parts Stock Soars After Earnings. 2026 Off to a ‘Solid Start,’ CEO Says.

Published

on

Advance Auto Parts Stock Soars After Earnings. 2026 Off to a ‘Solid Start,’ CEO Says.

Advance Auto Parts Stock Soars After Earnings. 2026 Off to a ‘Solid Start,’ CEO Says.

Continue Reading

Business

Walmart executives depart under CEO John Furner

Published

on

Walmart executives depart under CEO John Furner

A Walmart store is seen on Feb. 3, 2026 in Austin, Texas.

Brandon Bell | Getty Images

Two top Walmart executives are departing the company, nearly four months after CEO John Furner took over, CNBC learned on Friday.

Advertisement

Tom Ward, the chief operating officer of Walmart’s warehouse Sam’s Club, is retiring, while Cedric Clark, Walmart’s executive vice president of U.S. store operations, is leaving the business, internal memos viewed by CNBC shows. 

A replacement for Clark is expected to be announced in the “coming weeks,” the memo stated. It’s unclear when the company expects to fill Ward’s position. 

The leadership shuffle comes after Furner took over as Walmart’s CEO in February. Alongside Furner’s promotion, the company elevated four new top executives to work alongside him earlier this year. Seth Dallaire was promoted to chief growth officer, overseeing the company’s marketplace and advertising businesses, David Guggina was elevated to CEO of Walmart U.S., Chris Nicholas became CEO of Walmart International and Latriece Watkins became CEO of Sam’s Club. 

Furner took over the largest U.S. retailer during a period of sustained growth, fueled by gains with higher-income consumers and the expansion of its e-commerce business.

Advertisement

Walmart announced fiscal first-quarter earnings on Thursday, where it issued mixed results and said its business remained strong despite consumer pressures and high gas prices.

The leadership changes were first reported by the Wall Street Journal.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Millrose Properties: The 11% Yield Is Attractive, But Governance Risk Limits The Upside

Published

on

Millrose Properties: The 11% Yield Is Attractive, But Governance Risk Limits The Upside

Millrose Properties: The 11% Yield Is Attractive, But Governance Risk Limits The Upside

Continue Reading

Business

From decades to years – AI could speed search for brain drugs hiding in plain sight

Published

on

From decades to years - AI could speed search for brain drugs hiding in plain sight

Researchers hope the work will help identify affordable, effective drugs to treat conditions like MND.

Continue Reading

Business

Kylie Minogue Reveals Secret Second Cancer Diagnosis in 2021 Netflix Documentary

Published

on

Gemini Kylie Minogue

LONDON — Kylie Minogue disclosed in her new self-titled Netflix documentary that she received a second cancer diagnosis in early 2021, years after her successful treatment for breast cancer in 2005. The Australian singer, 57, chose to keep the news private at the time.

The documentary, released on Wednesday, May 20, 2026, features Minogue discussing the diagnosis. She stated: “My second cancer diagnosis was in early 2021. I was able to keep that to myself. Not like the first time.”

Minogue added: “Thankfully, I got through it, again, and all is well.” She noted that she decided against going public during the period, particularly amid the success of her 2023 single “Padam Padam,” which won a Grammy Award.

The pop star explained her decision to remain silent. “I don’t feel obliged to tell the world, and actually I just couldn’t at the time because I was just a shell of a person,” she said. “I didn’t want to leave the house again at one point.”

Advertisement

Minogue described the emotional difficulty of withholding the information. “Padam Padam opened so many doors for me but on the inside I knew that cancer wasn’t just a blip in my life,” she continued. “And I really just wanted to say what happened so I can let go of it. I’d sit through interviews and every opportunity I thought, ‘now’s the time’, but I kept it to myself.”

The documentary, directed by Michael Harte — who also directed the David Beckham documentary — spans three parts and explores Minogue’s career and personal life. She mentioned leaving subtle hints about her health battle on her 2023 album “Tension.” The track “Story” includes the lyrics: “I had a secret that I kept to myself / Turn another page, baby take the stage.”

Minogue was first diagnosed with breast cancer in May 2005 at age 36 while promoting her album “Fever.” She underwent surgery and chemotherapy, publicly announcing the diagnosis later that year. The treatment was successful, and she returned to performing in 2006.

Her second diagnosis came during the COVID-19 pandemic period. Minogue has not disclosed the specific type of cancer or details of the treatment she received in 2021. She emphasized in the documentary that she is now healthy.

Advertisement

The singer reflected on her passion for music as a source of strength. “Hey, who knows what’s around the corner, but pop music nurtures me… my passion for music is greater than ever,” she said.

Minogue rose to fame in the 1980s as a star on the Australian soap opera “Neighbours.” She launched her music career in 1987 with the hit “The Loco-Motion” and became a global pop icon with songs including “Can’t Get You Out of My Head,” “Spinning Around” and “Padam Padam.”

The Netflix documentary marks a significant personal revelation for the performer, who has sold more than 80 million records worldwide. It arrives as she continues active touring and recording.

Minogue has not scheduled additional public appearances immediately following the documentary release. She requested privacy regarding further details of her health journey.

Advertisement

The revelation has drawn widespread attention across entertainment media. Fans and fellow artists have expressed support on social media platforms following the documentary’s debut.

Minogue’s first cancer battle in 2005 raised significant awareness for breast cancer screening. She became an advocate for early detection and women’s health issues after her recovery.

Her career continued strongly after both health challenges. The 2023 album “Tension” and single “Padam Padam” marked a major commercial resurgence, introducing her music to a new generation of listeners.

The documentary provides context on how Minogue balanced her public persona with private struggles. Director Michael Harte captured intimate moments from her life and career spanning more than four decades.

Advertisement

No additional medical updates were provided beyond the statements in the film. Minogue stressed that she is currently well and focused on her music and future projects.

The release timing coincides with Minogue’s ongoing creative output. She has teased further music and performances in 2026 following the success of her recent work.

Industry observers note that Minogue’s decision to share her story now reflects a desire for closure while protecting her privacy during treatment. The documentary serves as both a career retrospective and a personal milestone.

Minogue’s management has not issued further statements beyond the content in the Netflix film. The project is available for streaming globally on the platform.

Advertisement

Her journey through two cancer diagnoses highlights the singer’s resilience. She has maintained an active schedule of recording, touring and public appearances in recent years.

The documentary has sparked renewed interest in Minogue’s catalog. Streaming numbers for her music, particularly tracks from “Tension,” increased following the film’s release.

Minogue continues to serve as an inspiration for many facing health challenges. Her public platform has amplified messages about perseverance and the importance of medical care.

As of May 22, 2026, no additional interviews or details about her 2021 diagnosis have been scheduled. The Netflix documentary remains the primary source of her comments on the matter.

Advertisement
Continue Reading

Business

Deckers Outdoor Is Stepping In The Right Direction (Upgrade)

Published

on

Deckers Outdoor Is Stepping In The Right Direction (Upgrade)

Deckers Outdoor Is Stepping In The Right Direction (Upgrade)

Continue Reading

Trending

Copyright © 2025